Literature DB >> 19699667

Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts.

Jessie M Cameron1, Valeriy Levandovskiy, Nevena MacKay, Rucha Utgikar, Cameron Ackerley, David Chiasson, William Halliday, Julian Raiman, Brian H Robinson.   

Abstract

We report here the identification of a patient with muscle-specific glycogen synthase deficiency. The 8-year-old patient showed no prior signs of distress before collapsing during a bout of exercise, resulting in death. Initial post-mortem analysis of tissues suggested death was due to metabolic complications of mitochondrial myopathy, but upon further examination it was found that the anomalies were indicative of mitochondrial proliferation and oxidative compensation. A homozygous two base pair deletion was identified in exon 2 of GYS1, and the parents and sibling were confirmed as heterozygous carriers of the deletion. This case highlights the importance of differentiating between mitochondrial compensatory phenomena and true mitochondrial disease, and suggests that GYS1 deficiency could be a common cause of sudden cardiac death in children. Children with abnormal cardiac responses to increased workloads as well as those with defined myocardial disease should therefore be tested for GYS1 deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699667     DOI: 10.1016/j.ymgme.2009.07.012

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 2.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

3.  Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1.

Authors:  H Orhan Akman; Yavuz Aykit; Ozge Ceren Amuk; Edoardo Malfatti; Norma B Romero; Maria Antonietta Maioli; Rachele Piras; Salvatore DiMauro; Gianni Marrosu
Journal:  Neuromuscul Disord       Date:  2015-11-10       Impact factor: 4.296

Review 4.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

5.  Proteomic analysis of ribosomes: translational control of mRNA populations by glycogen synthase GYS1.

Authors:  Gabriele Fuchs; Camille Diges; Lori A Kohlstaedt; Karen A Wehner; Peter Sarnow
Journal:  J Mol Biol       Date:  2011-05-05       Impact factor: 5.469

Review 6.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

7.  Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.

Authors:  Gaelle Douillard-Guilloux; Nina Raben; Shoichi Takikita; Arnaud Ferry; Alban Vignaud; Isabelle Guillet-Deniau; Maryline Favier; Beth L Thurberg; Peter J Roach; Catherine Caillaud; Emmanuel Richard
Journal:  Hum Mol Genet       Date:  2009-12-03       Impact factor: 6.150

Review 8.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

Review 9.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

10.  Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.

Authors:  Saija Ahonen; Silvia Nitschke; Tamar R Grossman; Holly Kordasiewicz; Peixiang Wang; Xiaochu Zhao; Dikran R Guisso; Sahba Kasiri; Felix Nitschke; Berge A Minassian
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.